Quantum BioPharma Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QNTM research report →
Companywww.quantumbiopharma.com
Quantum BioPharma Ltd. , a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments.
- CEO
- Zeeshan Saeed
- IPO
- 2018
- Employees
- 17
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $35.06M
- P/E
- -1.13
- P/S
- 0.00
- P/B
- 58.71
- EV/EBITDA
- -1.56
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -621.76%
- ROIC
- 819.14%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-26,175,286 · -84.30%
- EPS
- $-8.11 · 35.07%
- Op Income
- $-15,302,374
- FCF YoY
- -21.88%
Performance & Tape
- 52W High
- $38.25
- 52W Low
- $2.07
- 50D MA
- $4.21
- 200D MA
- $9.42
- Beta
- 0.29
- Avg Volume
- 460.07K
Get TickerSpark's AI analysis on QNTM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our QNTM Coverage
We haven't published any research on QNTM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QNTM Report →